These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 8900394)

  • 1. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R; Sobel M; McAdory LE; Harris RB
    Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy.
    Tyler-Cross R; Sobel M; Marques D; Harris RB
    Protein Sci; 1994 Apr; 3(4):620-7. PubMed ID: 8003980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
    Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
    Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.
    Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I
    Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
    Singh P; Singh K; Jairajpuri MA
    J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR; Petitou M; Björk I; Olson ST
    Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution.
    Mourey L; Samama JP; Delarue M; Petitou M; Choay J; Moras D
    J Mol Biol; 1993 Jul; 232(1):223-41. PubMed ID: 8331659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
    Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B; Brieditis I; Bock SC; Olson ST; Björk I
    Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
    Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern and spacing of basic amino acids in heparin binding sites.
    Fromm JR; Hileman RE; Caldwell EE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1997 Jul; 343(1):92-100. PubMed ID: 9210650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity interaction between a synthetic, highly negatively charged pentasaccharide and alpha- or beta-antithrombin is predominantly due to nonionic interactions.
    Hjelm R; Schedin-Weiss S
    Biochemistry; 2007 Mar; 46(11):3378-84. PubMed ID: 17323934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic analogues of the antithrombin III-binding pentasaccharide sequence of heparin. Prediction of in vivo residence times.
    van Amsterdam RG; Vogel GM; Visser A; Kop WJ; Buiting MT; Meuleman DG
    Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):495-503. PubMed ID: 7749861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site.
    Skinner R; Abrahams JP; Whisstock JC; Lesk AM; Carrell RW; Wardell MR
    J Mol Biol; 1997 Feb; 266(3):601-9. PubMed ID: 9067613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor.
    Fromm JR; Hileman RE; Caldwell EE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1995 Nov; 323(2):279-87. PubMed ID: 7487089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of heparin fractions to von Willebrand factor: effect of molecular weight and affinity for antithrombin III.
    Baruch D; Ajzenberg N; Denis C; Legendre P; Lormeau JC; Meyer D
    Thromb Haemost; 1994 Jan; 71(1):141-6. PubMed ID: 8165633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the antithrombin III heparin binding site.
    Ersdal-Badju E; Lu A; Zuo Y; Picard V; Bock SC
    J Biol Chem; 1997 Aug; 272(31):19393-400. PubMed ID: 9235938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
    Lormeau JC; Herault JP; Herbert JM
    Thromb Haemost; 1996 Jul; 76(1):5-8. PubMed ID: 8819242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide model for the heparin binding site of antithrombin III.
    Lellouch AC; Lansbury PT
    Biochemistry; 1992 Mar; 31(8):2279-85. PubMed ID: 1540583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.